Role of CD40 and B7 costimulators in inflammatory bowel diseases

Acta Biomedica de l'Ateneo Parmense

Volumn 74, Issue SUPPL. 2, 2003, Pages 65-70

  Polese, Lino ^a,b   Angriman, Imerio ^a   Scarpa, Marco ^a   Norberto, Lorenzo ^a   Sturniolo, Giacomo Carlo ^a   Cecchetto, Attilio ^a   Ruffolo, Cesare ^a   D'Amico, Davide Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

CD40; Crohn's disease; Ulcerative colitis

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CLINICAL TRIAL; COLON CROHN DISEASE; CONFERENCE PAPER; DRUG SCREENING; ENTERITIS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; IMMUNOTHERAPY; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; TH1 CELL; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 1542515288     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Radford-Smith G. Ulcerative colitis: an immunological disease? Baillerie's Clinical Gastroenterology 1991; 11: 35-52.
2. Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease QJM 1989; 72: 835-40.
3. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine Baltimore 1976; 55: 401-12.
4. Snook J. Are inflammatory bowel diseases autoimmune disorders? Gut 1990; 31: 961-3.
5. Stevens C, Peppercorn MA, Grand RJ. Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 1992; 15: 2-3.
6. Govindarajan R., Galpin OP. Coexistence of Addison's disease, ulcerative colitis, hypothyroidism and pernicious anemia. J Clin Gastroenterol 1992; 15: 82-3.
7. MacDermott RP, Nash GS et al. Altered patterns of secretion of IgA and IgG subclasses by ulcerative colitis and Crohn's disease intestinal mononuclear cells. Advances in Experimental Medicine and Biology 1987; 216A: 335-44.
8. MacDermott R, Beale M, et al. Syntesis and secretion of IgA, IgM and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs. In McGhee JR and Mestecky J eds The secretory Immune System
9. Scott B, Goodall A, et al. Rectal mucosa plasma cells in inflammatory bowel disease. Gut 1983; 24: 519-24.
10. Abad E, Tural C, Mirapeix E, Cuxart A. Relationship between ANCA and Clinical Activity in Inflammatory Bowel Disease: Variation in prevalence of ANCA and Evidence of Heterogeneity. Journal of Autoimmunity 1997; 10: 175-80.
11. Targan S, Landers C, et al. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. Journal of Immunology 1995; 155: 3262-326.
12. Mullin G, Lanzanby AJ, Harris ML, et al. Increased interleukin-2 messanger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992; 102: 1620-27.
13. Mullin G, Vezza F, Sampat A, et al. Abnormal IL10, RNA production in the intestinal lesions of inflammatory bowel disease. Gastroenterology 1993; 104: A751.
14. Mullin G, Maycon Z, Katz R, et al. IL-13 in the mucosal lesions of inflammatory bowel disease. Gastroenterology 1994; 106: A740.
15. Bajorath J, Aruffo A. Construction and analysis of a detailed three-dimensional model of the ligand binding domain of the human B cell receptor CD40. Proteins: Structure, Function and Genetics 1997; 2: 5 9-70.
16. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995; 92: 4342-6.
17. Van Kooten C, Gerritsma JSJ, Paape ME, van Es LA, Banchereau J, Daha MR. Possibile role for CD40-CD40L in regulation of interstizial infiltration in the Kidney. Kidney Int 1997; 513: 711-21.
18. Fernandez E, Vincente A, Zapata A. Establishment and characterization of cloned human thymic epithelial cell lines. Analysis of adhesion molecule expression and cytokine production. Blood 1994; 83: 3245-54.
19. Polese L, Angriman I, Cecchetto A, et al. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. European Journal of Gastroenterology and Hepatology 2002; 14: 237-41.
20. Liu Z, Colpaert S, D'Haens GR, et al. Hyperexpression of CD40 Ligand (CD154) in Inflammatory Bowel Disease and its Contribution to Pathogenic Cytokine Production. J Immunol 1999; 163: 4049-57.
21. Van Kooten C, Banchereau J. Functional Role of CD40 and its Ligand. Int Arch Allergy Immunol 1997; 113: 393-9.
22. Van Gool SW, Vandenberghe P, De Boer M, Ceuppens JL. CD80, CD86 and CD40 Provide Accessory Signals in a Multiple-Step T-Cell Activation Model. Immunological Reviews 1996; 153: 47-81.
23. Grewal IS, Flavell RA. The role of CD40 Ligand in Costimulation and T-Cell Activation. Immunological Reviews 1996; 153: 85-105.
24. Liu Z, Geboes K Colpaert S, Overbergh L, et al. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. J Immunol 2000; 164 (11): 6005-14.
25. Stuber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996; 183: 693-8.
26. Li W, Buzoni-Gatel D, Debbabi H, et al. CD40/CD154 ligation is required for the development of acute ileitis following oral infection with an intracellular pathogen in mice. Gastroenterology 2002; 122 (3): 762-73.
27. Boumpas DT, Furie R, Manzi S, et al. A short course of BG9588 (Anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis Arthritis & Rheumatism 2003; 4: 719-27.
28. Kalunian KC, Davis JC, Merrill JT, et al. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154. Arthritis & Rheumatism 2002; 46: 3251-8.
29. Dumont FJ. IDEC-131. IDEC/Eisai. Curr Opin Investig Drugs 2002; 3 (5): 725-34.
30. Sperling AI, Bluestone J A. The complexities of T-cell costimulation: CD28 and Beyond. Immunological Reviews 16; 153: 155-82.
31. Manzotti CN, Tipping H, Perry LCA, et al. Inhibition of Human T cell proliferation by CTLA-4 utilizes CD0 and requires CD25+ regulatory T cells. Eur J Immunol 2002; 32: 2888-96
32. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nature Reviews Immunology 2001; 1: 220-8.
33. Rugtveit J, Bakka A, Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 1997; 110: 104-13.
34. Scarpa M, Angriman I, Behboo R, et al. Costimulation molecules B7 and IFN" in the pathogenesis of inflammatory bowel disease. Hepato-Gastroenterology 2002; 49, Supplement I: XXX-XXXI.
35. Kuchroo VK, Das MP, Brown JA, et al. B7-1, and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-18.
36. Racke MK, Scott DE, O. Quigley L, et al. Distinct roles of B7.1 (CD80) and B7.2 (CD86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 1995; 96: 2195.
37. Miller SD, Vanderlugt CL, Lenschow DJ, et al. Blockade of CD28/B7.1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995; 3: 739.
38. Lenshow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181: 1145.
39. Liu Z, Geboes K, Hellings P, et al. B7 interaction with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. The Journal of Immunology 2001; 167: 1830-8.
40. Moreland LW, Alten R, Van den Bosch F, et al. Costimulatory Blockade in patients with rheumatoid arthritis. Arthritis & Rheumatism 2002; 46: 1470-9.